pharmaceutical investing Forward Pharma Appeals the Decision of the Opposition Division to Revoke the EP2801355 Patent
medical device investing AIT Therapeutics Receives Patent Allowance for Delivery of Inhaled Nitric Oxide at Concentrations of at Least 160ppm for Treatment of Bronchiolitis in Infants
pharmaceutical investing VistaGen Therapeutics Receives European Patent regarding Methods of Production for AV-101
pharmaceutical investing Cyclacel Announces Notice of Grant of New European Patent Covering Sapacitabine Pharmaceutical Formulations
Spartan Metals Identifies 537 Feet 0.23% WO3Eq or 0.31% MoEq During Historic Drilling Validation at Its Victorio Tungsten-Molybdenum Project, New Mexico
QIMC Reports Multiple Elevated Hydrogen Mud-Gas Readings Over 100m-250m Interval of DDH-26-04, Including a Peak Hydrogen Reading of 16.0%, Two Hydrogen Readings of 13.5%, and Nine Readings at or Above 5% Hydrogen
